Skip to main content
. Author manuscript; available in PMC: 2013 Aug 19.
Published in final edited form as: Cancer Chemother Pharmacol. 2009 May 7;65(1):67–71. doi: 10.1007/s00280-009-1003-z

Table 5.

Individual patient responses to Jinfukang administration (N = 21)

Variable Decrease
(<67% of value
for initial dose)		 No change
(67–133% of
value for
initial dose)		 Increase
(>133% of
value for
initial dose)
Concentration at 15 min 3 (14) 9 (43) 9 (43)
Concentration at 45 min 4 (19) 6 (29) 11 (52)
Area-under-the-curve
 at infinity		 2 (10) 7 (33) 12 (57)
Area-under-the-curve at
 final time point		 3 (14) 7 (33) 11 (52)
Clearance rate (L/h) 5 (24) 8 (38) 8 (38)
Volumes of distribution
 (Vd) by the steady-
 state method		 3 (14) 4 (19) 14 (67)